By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and Integrated DNA Technologies today announced a deal to manufacture, market, and commercialize small synthetic gene products.

The deal, the terms of which were not disclosed, calls for the companies to construct custom, synthetic, double-stranded nucleic acids up to 5 kilobases. IDT will combine its expertise in custom oligonucleotide manufacturing with Synthetic Genomics' technology to assemble small gene constructs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.